2020
DOI: 10.1016/j.hlc.2020.04.015
|View full text |Cite
|
Sign up to set email alerts
|

Contemporary Outcomes of Pulmonary Valve Endocarditis: A 16-Year Single Centre Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(24 citation statements)
references
References 13 publications
0
24
0
Order By: Relevance
“…Its diagnosis can be challenging and delayed due to presentation with nonspecific symptoms. [5][6][7][8][9] Major predisposing risk factors for PVE are IV drug use, implanted cardiac devices, congenital heart diseases, central venous catheters, hemodialysis, and immunosuppression. [3][4][5][6][7] In 28% of patients with PVE, no predisposing factor was identified.…”
Section: Case Presentationmentioning
confidence: 99%
See 3 more Smart Citations
“…Its diagnosis can be challenging and delayed due to presentation with nonspecific symptoms. [5][6][7][8][9] Major predisposing risk factors for PVE are IV drug use, implanted cardiac devices, congenital heart diseases, central venous catheters, hemodialysis, and immunosuppression. [3][4][5][6][7] In 28% of patients with PVE, no predisposing factor was identified.…”
Section: Case Presentationmentioning
confidence: 99%
“…[5][6][7][8][9] Major predisposing risk factors for PVE are IV drug use, implanted cardiac devices, congenital heart diseases, central venous catheters, hemodialysis, and immunosuppression. [3][4][5][6][7] In 28% of patients with PVE, no predisposing factor was identified. 8 In non-device-related right-sided IE in non-IV drug users, 43% of patients have no underlying heart disease, also 9% of patients had no risk factors or portal of entry.…”
Section: Case Presentationmentioning
confidence: 99%
See 2 more Smart Citations
“…In a cohort of congenital heart disease patients, 924 surgical pulmonic valve replacement were performed with 19 (2%) cases attributed to PVE, corresponding to an incidence of 333/100000 person years[ 16 ]. A large single-center cohort of 2124 adult patients (median age 41.5 years) with IE reported 24 cases of pulmonary valve endocarditis, of which 54.2% of cases occurred in the context of prosthetic valves[ 17 ].…”
Section: Epidemiologymentioning
confidence: 99%